Top

Heb

January 12, 2011 by staff 

Heb, Hemispherx BioPharma, Inc. (AMEX:”’HEB) jumped 1.36% to close at $ 0.520 and the total volume was negotiated 351,896.00 hands Monday against his average volume of 733,824.00. “HEB”a opened the day at 0.51 and he made an intraday low of $ 0.51 and an intraday high and 0.52. The stock has a low week 52 and 52 weeks and 0.44 and high 0.87. “Market capitalization is $ 70.33M and HEB”he 135.24M shares. Hemispherx movement Biopharma, Inc. (Hemispherx) is a specialty pharmaceutical engaged in the clinical development of new therapies based on the natural immune system enhancing technologies for the treatment Basic viral and immune system of chronic disorders. The Company focuses on two major technology platforms and drug Ampligen Alferon N injection. The commercial orientation for the application includes Ampligen as a treatment for chronic fatigue syndrome (CFS) and as an enhancer of a vaccine against influenza (adjuvant) for both the development of therapeutic and preventive vaccines. Alferon N injection Administration U.S. Food and Drug Administration (FDA) has approved a product with an indication for refractory or recurrent genital warts.

Report to Team

_________________________________________
Please feel free to send if you have any questions regarding this post , you can contact on

usspost@gmail.com

Disclaimer: The views expressed on this site are that of the authors and not necessarily that of U.S.S.POST.

Comments

Comments are closed.

Bottom